1De Clercq,Yamamoto N,Pauwels R,et al.Potent and selective inhibition of human immunodeficiency virus(HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event[J].Proc Natl Acad Sci USA,1992,89(12):5286-5290.
2Kinter A L,Umscheid C A,Arthos J,et al.HIV envelope induces virus expression from resting CD+4 T cells isolated from HIV-infected individuals in the aabsence of markers of cellular ctivation or apoptosis[J].J Immunol,2003,170(5):2449-2455.
3Kilby J M,Hopkins S,Venetta T M,et al.Potent suppression of HIV-1 replication in human by T-20,apeptide inhibitor of gp41-mediated virus entry[J].Nat Med,1998,4(11):1302-1307.
4Lalezari J P,Henry K,O'Hearn M,et al.Enfuvirtide,an HIV-1 fusion inhibitor,for drug-resistant HIV infection in North and South America[J].N Engl J Med,2003,348(22):2175-2185.
5Laborsse B,Labernardiere J L,Dam E,et al.Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors[J].J Virol,2003,77(2):1610-1613.
6Moore J P,Stevenson M.New targets for inhibitors of HIV-1 replication[J].Nat Rev Mol Cell Biol,2000,1(1):40-49.
8Baba M,Nishimura O,Kanzaki N,et al.A-small-molecule,nonpeptide CCR5 antagonsist with highly potent and selective anti-HIV-1 activity[J].Natl Acad Sci USA,1999,96:5698-5703.
9Trkola A,Ketas T J,Nagashima K A,et al.Potent,broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140[J].J Virol,2001,75(2):579-588.
10Gerlach L O,Skerlj R T,Bridger G J,et al.Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor[J].J Biol Chem,2001,276(17):14153-14160.
